Research Article
Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease,☆☆,

https://doi.org/10.1016/j.jnutbio.2015.04.009Get rights and content
Under a Creative Commons license
open access

Abstract

Nonalcoholic fatty liver disease (NAFLD) prevalence is increasing worldwide, with the affected US population estimated near 30%. Diet is a recognized risk factor in the NAFLD spectrum, which includes nonalcoholic steatohepatitis (NASH) and fibrosis. Low hepatic copper (Cu) was recently linked to clinical NAFLD/NASH severity. Simple sugar consumption including sucrose and fructose is implicated in NAFLD, while consumption of these macronutrients also decreases liver Cu levels. Though dietary sugar and low Cu are implicated in NAFLD, transcript-level responses that connect diet and pathology are not established. We have developed a mature rat model of NAFLD induced by dietary Cu deficiency, human-relevant high sucrose intake (30% w/w) or both factors in combination. Compared to the control diet with adequate Cu and 10% (w/w) sucrose, rats fed either high-sucrose or low-Cu diet had increased hepatic expression of genes involved in inflammation and fibrogenesis, including hepatic stellate cell activation, while the combination of diet factors also increased ATP citrate lyase and fatty acid synthase gene transcription (fold change >2, P<0.02). Low dietary Cu decreased hepatic and serum Cu (P≤0.05), promoted lipid peroxidation and induced NAFLD-like histopathology, while the combined factors also induced fasting hepatic insulin resistance and liver damage. Neither low Cu nor 30% sucrose in the diet led to enhanced weight gain. Taken together, transcript profiles, histological and biochemical data indicate that low Cu and high sucrose promote hepatic gene expression and physiological responses associated with NAFLD and NASH, even in the absence of obesity or severe steatosis.

Abbreviations

ALT
alanine transaminase
CARS
coherent anti-Stokes Raman scattering
Cu
copper
Fe
iron
CuA
copper adequate
CuD
copper deficient
ECM
extracellular matrix
EMT
epithelial-to-mesenchymal transition
FC
fold change
FFA
free fatty acid
FGF
fibroblast growth factor
H&E
hematoxylin and eosin
HFCS
high-fructose corn syrup
HOMA-IR
homeostatic model assessment of insulin resistance
HSC
hepatic stellate cell
ICP-MS
inductively coupled mass spectrometry
IL
interleukin
IPA
Ingenuity Pathways Analysis
MDA
malondialdehyde
MetS
metabolic syndrome
NAFLD
nonalcoholic fatty liver disease
NASH
nonalcoholic steatohepatitis
ORO
oil red O
PBS
phosphate-buffered saline
qRT-PCR
quantitative reverse transcription polymerase chain reaction
TBARS
thiobarbituric acid reactive substances
TG
triglyceride
TNF
tumor necrosis factor

Keywords

Liver
Copper
Inflammation
Fibrosis
Steatosis
Nonalcoholic steatohepatitis

Cited by (0)

Disclosures: The authors have no conflicts of interest to disclose.

☆☆

Transcript profiling: Transcript profile data are deposited in the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE58875.

Author contributions: ST: acquisition of data, analysis and interpretation of data, drafting of the manuscript, statistical analysis; MD: acquisition of data, analysis of data; MR: analysis and interpretation of data, critical revision of manuscript; MPC: analysis and interpretation of data; ML: analysis and interpretation of data, critical revision of manuscript; JLB: acquisition of data, analysis and interpretation of data, drafting of the manuscript, statistical analysis, study concept and design.